Form 4: Inari Medical Director Robert Warner Reports Stock Transaction

Director Robert Warner of Inari Medical, Inc. reports acquisition and disposal of common stock on April 24, 2024.

Summary

• On April 24, 2024, Robert Keith Warner, a director of Inari Medical, Inc., engaged in a transaction involving the company's common stock.
• Warner acquired 4,126 shares of common stock at a price of $42.41 per share.
• Following the reported transaction, Warner beneficially owns 12,149 shares.
• The acquisition of 4,126 shares represents restricted stock units granted on April 24, 2024, vesting fully on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider trading activity.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, such as directors and officers, trade in their company's stock. This provides transparency to the market regarding insider activity.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value and prospects.

Key Dates